201 related articles for article (PubMed ID: 11435579)
1. Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.
Logg CR; Logg A; Tai CK; Cannon PM; Kasahara N
J Virol; 2001 Aug; 75(15):6989-98. PubMed ID: 11435579
[TBL] [Abstract][Full Text] [Related]
2. Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.
Logg CR; Baranick BT; Lemp NA; Kasahara N
J Mol Biol; 2007 Jun; 369(5):1214-29. PubMed ID: 17498744
[TBL] [Abstract][Full Text] [Related]
3. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus.
Erlwein O; Buchholz CJ; Schnierle BS
J Gen Virol; 2003 Feb; 84(Pt 2):369-373. PubMed ID: 12560569
[TBL] [Abstract][Full Text] [Related]
4. Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers.
Levenson VV; Transue ED; Roninson IB
Hum Gene Ther; 1998 May; 9(8):1233-6. PubMed ID: 9625263
[TBL] [Abstract][Full Text] [Related]
5. Transgene stability for three replication-competent murine leukemia virus vectors.
Duch M; Carrasco ML; Jespersen T; Hansen BD; Pedersen FS
Gene; 2004 Mar; 329():61-9. PubMed ID: 15033529
[TBL] [Abstract][Full Text] [Related]
6. Breeding of retroviruses by DNA shuffling for improved stability and processing yields.
Powell SK; Kaloss MA; Pinkstaff A; McKee R; Burimski I; Pensiero M; Otto E; Stemmer WP; Soong NW
Nat Biotechnol; 2000 Dec; 18(12):1279-82. PubMed ID: 11101807
[TBL] [Abstract][Full Text] [Related]
7. Possible role of splice acceptor site in expression of unspliced gag-containing message of Moloney murine leukemia virus.
Oshima M; Odawara T; Matano T; Sakahira H; Kuchino Y; Iwamoto A; Yoshikura H
J Virol; 1996 Apr; 70(4):2286-95. PubMed ID: 8642655
[TBL] [Abstract][Full Text] [Related]
8. Expression of heterologous genes from an IRES translational cassette in replication competent murine leukemia virus vectors.
Jespersen T; Duch M; Carrasco ML; Warming S; Pedersen FS
Gene; 1999 Nov; 239(2):227-35. PubMed ID: 10548723
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus.
Fisher J; Goff SP
Virology; 1998 Apr; 244(1):133-45. PubMed ID: 9581786
[TBL] [Abstract][Full Text] [Related]
10. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
Parthasarathi S; Varela-Echavarría A; Ron Y; Preston BD; Dougherty JP
J Virol; 1995 Dec; 69(12):7991-8000. PubMed ID: 7494312
[TBL] [Abstract][Full Text] [Related]
11. [Effect of internal sequences in the Moloney murine leukemia virus genome on replication].
Fomin IK; Lobanova AB; Voĭtenok NN
Genetika; 1995 Nov; 31(11):1490-7. PubMed ID: 8666218
[TBL] [Abstract][Full Text] [Related]
12. Deletion of a short, untranslated region adjacent to the polypurine tract in Moloney murine leukemia virus leads to formation of aberrant 5' plus-strand DNA ends in vivo.
Bacharach E; Gonsky J; Lim D; Goff SP
J Virol; 2000 May; 74(10):4755-64. PubMed ID: 10775614
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein.
Thomas A; Gray KD; Roth MJ
Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129
[TBL] [Abstract][Full Text] [Related]
14. Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses.
Steidl S; Schüle S; Mühlebach MD; Stitz J; Boller K; Cichutek K; Schweizer M
J Gen Virol; 2004 Mar; 85(Pt 3):665-678. PubMed ID: 14993652
[TBL] [Abstract][Full Text] [Related]
15. Rapid reversion of a deletion mutation in Moloney murine leukemia virus by recombination with a closely related endogenous provirus.
Martinelli SC; Goff SP
Virology; 1990 Jan; 174(1):135-44. PubMed ID: 2294637
[TBL] [Abstract][Full Text] [Related]
16. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.
Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D
J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710
[TBL] [Abstract][Full Text] [Related]
17. Cis-acting elements required for strong stop acceptor template selection during Moloney murine leukemia virus reverse transcription.
Topping R; Demoitie MA; Shin NH; Telesnitsky A
J Mol Biol; 1998 Aug; 281(1):1-15. PubMed ID: 9680471
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated targeting of replication-competent retroviral vectors.
Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
[TBL] [Abstract][Full Text] [Related]
19. Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group.
Prassolov V; Hein S; Ziegler M; Ivanov D; Münk C; Löhler J; Stocking C
J Virol; 2001 May; 75(10):4490-8. PubMed ID: 11312319
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary studies on the design of retroviral vectors for substitutive gene therapy].
Martín F; Jean-Mairet Y; Talavera A
Microbiologia; 1996 Mar; 12(1):43-50. PubMed ID: 9019133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
